North Carolina experts discussed CLL, breast cancer, and myeloma treatments and how to expand access to complex cancer care beyond academic centers.
|Articles|January 10, 2019
Managed Care News and Research: Quarter 1 2019
For more than 20 years, The American Journal of Managed Care® (AJMC®) has been the leading peer-reviewed journal dedicated to issues in managed care, disseminating clinical information to managed care physicians, clinical decision-makers, and other healthcare professionals. As the managed care landscape has evolved over the past two decades, AJMC® has been a consistent presence for professionals, expanding to digital platforms and means of delivering the latest Managed Care News and Research. Access leading information pertinent to your business with AJMC®
Advertisement
Advertisement
Related to this article
The IRA's Medicare out-of-pocket cap is easing costs for patients with cancer, but community oncology leaders warn price cuts are straining practices.
A follicular lymphoma survivor shares axi-cel CAR T-cell therapy highs, experiences with severe CRS and neurotoxicity, and why access to care and clinical trials improve quality of life.
Biomarker testing, referrals, screening, treatment access, and clinical trial barriers were examined during this recent IVBM.
Oncologists say advances in testing and treatment are outpacing staffing, pay, and access.
Home NB-UVB phototherapy matches office results, boosts psoriasis treatment adherence, and may improve access, but long-term safety, equity, and oversight lag.
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
Advertisement
Advertisement